3.1.1.23 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21459826&form=6&db=m Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. causal interaction,unassigned 1,0 3.1.1.23 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23122958&form=6&db=m Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. causal interaction,therapeutic application,unassigned 4,4,0 3.1.1.23 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28733897&form=6&db=m Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors. ongoing research,therapeutic application,unassigned 2,1,0 3.1.1.23 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32483456&form=6&db=m Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. causal interaction,therapeutic application,unassigned 3,3,0 3.1.1.23 Arthralgia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31937359&form=6&db=m Combatting joint pain and inflammation by dual inhibition of monoacylglycerol lipase and cyclooxygenase-2 in a rat model of osteoarthritis. ongoing research,therapeutic application,unassigned 1,1,0 3.1.1.23 Arthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26791214&form=6&db=m Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats. causal interaction,therapeutic application,unassigned 1,2,0 3.1.1.23 Arthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34042520&form=6&db=m Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis. causal interaction,therapeutic application,unassigned 2,1,0 3.1.1.23 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30609444&form=6&db=m Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner. causal interaction,unassigned 4,0 3.1.1.23 Brain Injuries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22821058&form=6&db=m Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. causal interaction,ongoing research,unassigned 2,1,0 3.1.1.23 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16685433&form=6&db=m Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia. diagnostic usage,ongoing research,unassigned 3,3,0